The acute respiratory syndrome market was valued at USD 15.42 Billion in 2024, driven by the increasing cases of allergic rhinitis across the 8 major markets. It is anticipated to grow at a CAGR of 4.20% during the forecast period of 2025-2034, with the values likely to reach USD 23.27 Billion by 2034.
Base Year
Historical Year
Forecast Year
One of the major market trends include an increasing number of drug approvals for treating the condition effectively. There is also an emphasis on improving access and efficacy of therapies to meet the rising need patient-focused solutions.
The market is witnessing increasing innovations, aimed at improving patient outcomes. For instance, there is a preference towards using non-sedating antihistamines to enhance the quality of life and productivity of patients.
The United States leads the market because of its strong regulatory network, substantial healthcare fundings, and the presence of top pharmaceutical companies advancing research and treatment in the region.
The allergic rhinitis market is a common immune reaction to allergens in the environment including pollen and airborne irritants like smoke, dust and other innumerable factors. The growing awareness concerning allergic rhinitis, improved diagnostic aids, and a surge in healthcare investment for research and development, drives the market growth. In addition, the increasing number of drug approvals, inclination towards personalized treatments, and an increase in the preference for non-drowsy antihistamines strengthen the approach towards treatment accessibility and efficacy.
Rising Prevalence of Allergic Rhinitis Drives Market Growth
Allergic rhinitis is the most common upper airway immunologic disorder seen all around the world, affecting around 10–40% of the population. The condition is further aggravated by the increase in environmental pollution, and pollen exposure, putting focus on allergy management. Such factors boost market growth by stimulating the increasing demand for effective treatments with antihistamines, intranasal corticosteroids, and immunotherapy. The market value is also impacted by enhanced diagnostics, and a global rise in healthcare spending.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Treatment
Market Breakup by Route of Administration
Market Breakup by Distribution Channel
Market Breakup by Region
Market Segmentation Based on the Treatment Set to Witness Substantial Growth
Based on treatment, the market is segmented into antihistamines, immunotherapy, corticosteroids, decongestants, and others. Among these, antihistamines are expected to lead the market because of their ability to control symptoms such as sneezing, itching, and a runny nose. They are also available in various forms such as oral tablets and nasal sprays, hence, they are easily available as over-the-counter products.
Based on region, the market report covers the United States, EU-4 (Germany, France, Italy, and Spain), the United Kingdom, Japan, and India. Among these, the United States is expected to dominate the market due to its supportive regulatory environment, leading to a rise in drug approvals. Moreover, the market value is further enhanced by the inclusion of major healthcare and pharmaceutical companies in the region.
EU-4 and the United Kingdom are also expected to have a substantial market share due to the rise of novel biotechnology firms in the region. There has been a surge in investments and funding to back emerging talent with the potential to integrate the newest techniques into drug development procedures.
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Sanofi is a global pharmaceutical leader based in Paris, France. Sanofi has developed fexofenadine (sold under the name Allegra), which is a widely prescribed antihistamine for symptomatic treatment.
Dr. Reddy's Laboratories Ltd., based in Hyderabad, India, is a global pharmaceutical company recognized for its generic medicines. The company offers products like Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets to offer ideal therapy for allergic rhinitis patients.
Teva Pharmaceutical Industries Ltd., headquartered in Petah Tikva, Israel, is one of the world's top pharmaceutical companies. The company manufactures different generic formulas of diverse antihistamines and corticosteroids like fluticasone propionate nasal spray, which can help manage symptoms of allergic rhinitis.
Novartis AG is a global pharmaceutical company based in Basel, Switzerland. Novartis completed the research and development of ketotifen, which is an antihistamine and mast cell stabilizer applied in the treatment of allergic rhinitis and some allergic conditions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include GlaxoSmithKline PLC, Boehringer Ingelheim, Unichem Laboratories Ltd., Meda AB, Viatris (Mylan NV), and Glenmark Pharmaceuticals Limited.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Treatment |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,969
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share